Advanced clinical-stage biopharmaceutical company, Pharnext, has issued 8,100 warrants giving access to bonds convertible into new shares, or exchangeable into existing shares, with Alpha Blue Ocean, the London-based alternative credit…
Advanced clinical-stage biopharmaceutical company, Pharnext, has issued 8,100 warrants giving access to bonds convertible into new shares, or exchangeable into existing shares, with Alpha Blue Ocean, the London-based alternative credit…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference